Xencor
XNCR
$24.11
Share price
2.03%
Change (1 day)
-12.77%
Change (1 year)
Categories
Xencor (XNCR) - Total debt
Total debt on the balance sheet as of December 2023 : $83.43 M
According to Xencor's latest financial reports the company's total debt is $83.43 M. A company’s total debt is the sum of all current and non-current debts.
Xencor - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $83.43 M | 39.91% |
| 2022-12-31 | $59.63 M | 75.55% |
| 2021-12-31 | $33.96 M | 192.13% |
| 2020-12-31 | $11.62 M | 8.33% |
| 2019-12-31 | $10.73 M | |
| 2018-12-31 | $N/A | |
| 2013-12-31 | $0.01 M | -99.95% |
| 2012-12-31 | $20.94 M | 13.35% |
| 2011-12-31 | $18.47 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 35,055.93% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 71,076.02% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 77,342.05% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 41,915.25% | 🇺🇸 USA |
 Seagen
SGEN | $0.11 B | 36.02% | 🇺🇸 USA |
 MacroGenics MGNX | $33.97 M | -59.28% | 🇺🇸 USA |